Combination Therapy of Teriparatide and Anti-RANKL Monoclonal Antibody Increases Bone Mass and Promotes Bone Regeneration of Glucocorticoid-Induced Osteoporosis in Mice.

被引：0
|
作者：
Etani, Yuki
Okamura, Gensuke
Ebina, Kosuke
Hirao, Makoto
Miyama, Akira
Yoshikawa, Hideki
Takami, Kenji
机构：
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-46
引用
收藏
页码：189 / 189
页数：1
相关论文
共 19 条
  • [1] Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis
    Etani, Yuki
    Ebina, Kosuke
    Hirao, Makoto
    Kitaguchi, Kazuma
    Kashii, Masafumi
    Ishimoto, Takuya
    Nakano, Takayoshi
    Okamura, Gensuke
    Miyama, Akira
    Takami, Kenji
    Goshima, Atsushi
    Kanamoto, Takashi
    Nakata, Ken
    Yoshikawa, Hideki
    BONE, 2020, 139
  • [2] Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice
    Kitaguchi, Kazuma
    Kashii, Masafumi
    Ebina, Kosuke
    Kaito, Takashi
    Okada, Rintaro
    Makino, Takahiro
    Noguchi, Takaaki
    Ishimoto, Takuya
    Nakano, Takayoshi
    Yoshikawa, Hideki
    BONE, 2018, 106 : 1 - 10
  • [3] The combined effects of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in ovariectomized mice
    Kitaguchi, Kazuma
    Kashii, Masafumi
    Ebina, Kosuke
    Kaito, Takashi
    Okada, Rintaro
    Makino, Takahiro
    Etani, Yuki
    Ishimoto, Takuya
    Nakano, Takayoshi
    Yoshikawa, Hideki
    BONE, 2020, 130
  • [4] Metabolic bone diseases: Teriparatide or alendronate for glucocorticoid-induced osteoporosis therapy?
    Nassabeh N.
    Nature Reviews Rheumatology, 2010, 6 (1) : 1 - 1
  • [5] Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy
    Soher Nagi Jayash
    Dounia Hamoudi
    Louise A. Stephen
    Anteneh Argaw
    Carmen Huesa
    Shuko Joseph
    Sze Choong Wong
    Jérôme Frenette
    Colin Farquharson
    Calcified Tissue International, 2023, 113 : 449 - 468
  • [6] Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy
    Jayash, Soher Nagi
    Hamoudi, Dounia
    Stephen, Louise A.
    Argaw, Anteneh
    Huesa, Carmen
    Joseph, Shuko
    Wong, Sze Choong
    Frenette, Jerome
    Farquharson, Colin
    CALCIFIED TISSUE INTERNATIONAL, 2023, 113 (04) : 449 - 468
  • [7] The effect of switching from teriparatide to anti-RANKL antibody on cancellous and cortical bone in ovariectomized mice
    Omiya, Toshinobu
    Hirose, Jun
    Hasegawa, Tomoka
    Amizuka, Norio
    Omata, Yasunori
    Izawa, Naohiro
    Yasuda, Hisataka
    Kadono, Yuho
    Matsumoto, Morio
    Nakamura, Masaya
    Miyamoto, Takeshi
    Tanaka, Sakae
    BONE, 2018, 107 : 18 - 26
  • [8] Anti-RANKL monoclonal antibody and bortezomib prevent mechanical unloading-induced bone loss
    Ding, Yi
    Cui, Yu
    Yang, Xi
    Wang, Xiaolu
    Tian, Guangzhao
    Peng, Jiang
    Wu, Bo
    Tang, Li
    Cui, Chun-Ping
    Zhang, Lingqiang
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (06) : 974 - 983
  • [9] AMG-162.: Treatment of osteoporosis bone cancer therapy treatment of rheumatoid arthritis human anti-RANKL monoclonal antibody
    McIntyre, JA
    Martín, L
    DRUGS OF THE FUTURE, 2005, 30 (03) : 237 - 239
  • [10] Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody
    Kamijo, Seiji
    Nakajima, Atsuo
    Ikeda, Kaori
    Aoki, Kazuhiro
    Ohya, Keiichi
    Akiba, Hisaya
    Yagita, Hideo
    Okumura, Ko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (01) : 124 - 132
12